Abstract
Department of Women's Health, Dell Medical School, University of Texas at Austin, and the Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas Financial Disclosure Dr. Moise received funding from Janssen Pharmaceuticals, Inc., paid on his behalf to Dell Medical School at the University of Texas at Austin for a clinical trial on a monoclonal antibody for the treatment of hemolytic disease of the fetus and newborn. He received royalty funding from UpToDate, Inc., for authorship on various chapters. He received consulting fees from Health Management Associates, Inc., for consultation on the formation of fetal centers, and from BillionToOne, Inc., paid on his behalf to Dell Medical School at the University of Texas at Austin. He received honoraria from GLC Healthcare, Inc., for podcast content on hemolytic disease of the fetus and newborn. Lastly, Dr. Moise serves as a non-paid consultant for Immunology for Janssen Pharmaceuticals, Inc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
